Background illustration for clinical trials search

Paid Clinical Trials St. Louis

Discover 1,406 paid clinical trials in St. Louis, Missouri. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,406

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

for

Anatomic Stage II Breast Cancer AJCC v8,

Location: St Louis MO, O'Fallon IL, Ballwin MO,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07391774

Phase 3, Recruiting

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

for

Metastatic Castration-Resistant Prostate Carcinoma,

Location: St Louis MO, O'Fallon IL, Mount Vernon IL, Decatur IL,

Sponsor: Alliance for Clinical Trials in Oncology

Sex: Male

Age: 18+

Code: NCT07200830

Phase 3, Recruiting

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

for

Advanced Clear Cell Renal Cell Carcinoma,

Location: St Louis MO, Sainte Genevieve MO, Farmington MO,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT07383441

Phase 3, Recruiting

Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

for

Advanced Lung Neuroendocrine Tumor,

Location: St Louis MO, New Lenox IL, Orland Park IL, Chicago IL,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04665739

Phase 2, Recruiting

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

for

Myelodysplastic Syndrome

Location: St Louis MO, O'Fallon IL, Sainte Genevieve MO,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06577441

Phase 2, Recruiting

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

for

Non-small Cell Lung Cancer

Location: St Louis MO, Hinsdale IL, North Chicago IL,

Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06350097

Phase 3, Recruiting

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for

Acute Coronary Syndrome

Location: St Louis MO, Springfield IL, Newburgh IN, Davenport IA,

Sponsor: DalCor Pharmaceuticals

Sex: All

Age: 45+

Code: NCT05918861

Phase 3, Recruiting

Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation

for

Delayed Graft Function, DGF, Kidney Transplant

Location: St Louis MO, Fairway KS, Nashville TN, Chicago IL,

Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06830798

Phase 3, Recruiting

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

for

Melanoma, Non-small Cell Lung Cancer,

Location: St Louis MO, Grand Rapids MI, Pittsburgh PA, Houston TX,

Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07115043

Phase 1, Phase 2, Recruiting

A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)

for

Multiple Myeloma

Location: St Louis MO, Iowa City IA, Nashville TN, Atlanta GA,

Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07073547

Phase 1, Recruiting

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

for

Chronic Obstructive Pulmonary Disease (COPD)

Location: St Louis MO, Chesterfield MO, Hannibal MO, Franklin TN,

Sponsor: AstraZeneca

Sex: All

Age: 40+

Code: NCT07082738

Phase 2, Recruiting

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

for

Non-small Cell Lung Cancer, Colorectal Carcinoma,

Location: St Louis MO, Westwood KS, Nashville TN, Chicago IL,

Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06218914

Phase 1, Recruiting

Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol

for

Binge-Eating Disorder

Location: Saint Charles MO, Overland Park KS, Memphis TN,

Sponsor: Axsome Therapeutics, Inc.

Sex: All

Age: 18 - 55

Code: NCT06413433

Phase 3, Recruiting

A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.

for

Relapsed AL Amyloidosis, Refractory AL Amyloidosis,

Location: St Louis MO, Nashville TN, Rochester MN, Detroit MI,

Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07081646

Phase 1, Phase 2, Recruiting

Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis

for

Liver Fibrosis, Hepatic Cirrhosis

Location: St Louis MO, Clarksville TN, Kansas City MO, Yukon OK,

Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07610837

Phase 2, Recruiting

Study to Evaluate the Safety and Tolerability of Camizestrant in Combination With Atirmociclib in Women With Advanced Breast Cancer

for

Advanced Breast Cancer

Location: St Louis MO, Nashville TN, East Providence RI

Sponsor: AstraZeneca

Sex: Female

Age: 18+

Code: NCT07427394

Phase 2, Recruiting

Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis

for

Severe Hypertriglyceridemia

Location: St Louis MO, Indianapolis IN, Kansas City KS,

Sponsor: Arrowhead Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06880770

Phase 3, Recruiting

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

for

Asthma

Location: St Louis MO, Normal IL, Indianapolis IN, Kansas City MO,

Sponsor: AstraZeneca

Sex: All

Age: 12 - 17

Code: NCT06307665

Phase 3, Recruiting

Child and Adolescent Registry for Participants With Narcolepsy

for

Narcolepsy

Location: Chesterfield MO, Kansas City MO, Little Rock AR,

Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 0 - 17

Code: NCT04899947

Recruiting

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

for

Metastatic Clear Cell Renal Cell Carcinoma,

Location: St Louis MO, Indianapolis IN, Louisville KY,

Sponsor: Arcus Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT07011719

Phase 3, Recruiting

Paid Clinical Trials St. Louis

Filter results

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

Interested in new trials?

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol

A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.

Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis

Study to Evaluate the Safety and Tolerability of Camizestrant in Combination With Atirmociclib in Women With Advanced Breast Cancer

Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

Child and Adolescent Registry for Participants With Narcolepsy

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma